Results 271 to 280 of about 130,065,242 (295)
Some of the next articles are maybe not open access.
Current opinion in drug discovery & development, 2004
Drug 'developability' assessment has become an increasingly important addition to traditional drug efficacy and toxicity evaluations, as pharmaceutical scientists strive to accelerate drug discovery and development processes in a time- and cost-effective manner.
Duxin, Sun +5 more
openaire +1 more source
Drug 'developability' assessment has become an increasingly important addition to traditional drug efficacy and toxicity evaluations, as pharmaceutical scientists strive to accelerate drug discovery and development processes in a time- and cost-effective manner.
Duxin, Sun +5 more
openaire +1 more source
In Vitro Toxicity Model: Upgrades to Bridge the Gap Between Preclinical and Clinical Research
Biomolecules and Biomedicine, 2020Uroš Maver +2 more
exaly
Development of In Vitro Preclinical Models for Testing Tumor-Stroma Interactions in PDAC
PancreatologyBozena Smolkova +11 more
openaire +1 more source
[Different viewpoints on preclinical immunotoxicologic tests in vivo and in vitro].
Ceskoslovenska farmacie, 1989J, Procházková +2 more
openaire +1 more source
In Vitro Preclinical Models for a Rational Design of Chemotherapy Combinations in Human Tumors
Critical Reviews in Oncology/Hematology, 2001Anna Tesei, L Ricotti, Wainer Zoli
exaly
RF67. Preclinical in-vitro and in-vivo testing of an antibacterial, absorbable annuloplasty ring
The Journal of Thoracic and Cardiovascular SurgeryBruno Podesser +13 more
openaire +1 more source

